13F filing recap · Q3 2025
What did Scion Asset Management buy in Q3 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$68.14M
Positions
4
Estimated turnover
166.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Scion Asset Management opened new positions in Molina Healthcare, Slm Corp, and Bruker Corporation, while exiting Bruker Corporation, Estee Lauder Companies, Mercadolibre, Regeneron Pharmaceuticals, and UnitedHealth Group. The firm also sharply increased its stake in Lululemon Athletica.